The SCF-type E3 Ubiquitin Ligases as Cancer Targets

E-ISSN： 1873-5576|16|2|119-129

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.16, Iss.2, 2016-02, pp. : 119-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SCF E3 Ubiquitin Ligases as Anticancer Targets

Current Cancer Drug Targets, Vol. 11, Iss. 3, 2011-03 ,pp. : 347-356

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Ubiquitin E3 Ligases as Molecular Targets or Tools for Advanced Cancer Therapy)

Current Cancer Drug Targets, Vol. 16, Iss. 2, 2016-02 ,pp. : 100-100

Bentham Science Publishers

Access to resources Recommend Favorite

E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers

Current Cancer Drug Targets, Vol. 16, Iss. 2, 2016-02 ,pp. : 130-135

Bentham Science Publishers

Access to resources Recommend Favorite

RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer

Current Cancer Drug Targets, Vol. 16, Iss. 2, 2016-02 ,pp. : 157-174

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of Epithelial-Mesenchymal Transition by E3 Ubiquitin Ligases and Deubiquitinase in Cancer

Current Cancer Drug Targets, Vol. 16, Iss. 2, 2016-02 ,pp. : 110-118

Bentham Science Publishers

Access to resources Recommend Favorite